HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups...
HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes
About this item
Full title
Author / Creator
Krishnan, Sridevi , Shimoda, Michiko , Sacchi, Romina , Kailemia, Muchena J. , Luxardi, Guillaume , Kaysen, George A. , Parikh, Atul N. , Ngassam, Viviane N. , Johansen, Kirsten , Chertow, Glenn M. , Grimes, Barbara , Smilowitz, Jennifer T. , Maverakis, Emanual , Lebrilla, Carlito B. and Zivkovic, Angela M.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The goal of this pilot study was to determine whether HDL glycoprotein composition affects HDL’s immunomodulatory function. HDL were purified from healthy controls (n = 13), subjects with metabolic syndrome (MetS) (n = 13), and diabetic hemodialysis (HD) patients (n = 24). Concentrations of HDL-bound serum amyloid A (SAA),
lipopolysaccharide
...
Alternative Titles
Full title
HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5347119
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5347119
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/srep43728
